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This study presents a simple approach for the noninvasive assignment of glial brain tumors ac- 
cording to malignancy by single-voxel proton magnetic resonance spectroscopy at short echo times 
(TE ~ 50 milliseconds). Based on peak area ratios, a five-dimensional data set was obtained for each 
investigated subject. This vector was then projected along metabolic oordinates in a two- 
dimensional metabolic space. These coordinates had been determined in a previous tudy (Hagberg 
Get al., 1995, Magn Reson Med 34" 242-252). Tumor assignment was done without any knowledge 
of histology by comparing the location of the new cases to the features of the previous tudy. All 11 
investigated glioblastomas multiforme, as well as 4 of 5 astrocytomas grade II, could easily be 
assigned to the groups of high- and low-grade tumors, respectively. Classification was more diffi- 
cult in the case of a cystic astrocytoma grade II and one astrocytoma grade III. Two spectra mea- 
sured in normal-appearing matter of glioblastoma patients were not classified as healthy. Using 
single-voxel proton magnetic resonance spectroscopy at short echo times with the knowledge of a 
base study, a straightforward, fast, and noninvasive differential diagnosis of glial brain tumors is 
possible. 
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INTRODUCTION 
The histological assignment of human brain tumors 
using different localized 1H-magnetic resonance spec- 
troscopy (1H-MRS) techniques is a long-standing 
problem. Several investigators have tried to find or 
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describe tumor-specific spectra [1]. However, most of 
these studies have been performed using longer echo 
times (e.g., TE = 135-272 milliseconds). In those mea- 
surements the definition of the baseline is improved at 
the expense of the visibility of resonances having 
shorter relaxation times or being strongly coupled, 
such as myo-inositol, glutamine, glutamate, lipids, or 
proteins. Important additional metabolic information 
can thus be obtained using shorter TE. However, a 
diagnosis based on single peaks in short echo time 
MRS is still very difficult because the spectral patterns 
of different umor types show some trends but overlap 
in a wide range [1-3]. 
Howells et al. [4,5] presented a method to improve 
the spectral analysis of rat tumors using automated 
procedures. According, the information content of all 
metabolites together can be extracted using cluster 
analysis both with [4--6] or without [6,7] feature ex- 
traction techniques [8]. First applications of this 
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method to in vivo proton spectra of the human brain 
were presented by Confort-Gouny et al. [9]. 
The purpose of the present study was to apply the 
metabolic features found in a previous study of 21 
healthy controls and humans with gliomas [6] to a 
new cohort of patients with a suspected glial brain 
tumor and other healthy volunteers. The new cases, 
investigated on a different magnetic resonance (MR) 
scanner, were classified by observing their location 
within the previous features as low-grade or high- 
grade gliomas or as healthy. 
MATERIALS AND METHODS 
Data acquisition and postprocessing 
Thirty-five spectra of 17 patients with a suspected glial 
brain tumor and 9 healthy volunteers (HV) were in- 
vestigated at 1.5 T with a Siemens Magnetom SP 4000 
MR system (Siemens Medical Systems, Erlangen, Ger- 
many) using the standard circularly polarized head 
coil. After image-guided localization, the position of 
the cubic volume of interest of 8 mL was chosen to be 
as close as possible to the center of the tumor, so that 
the volume of interest was filled with at least 75% 
tumor tissue. A STEAM sequence with an echo time of 
50 milliseconds was used, the mixing and repetition 
times were 30 milliseconds and 1500 milliseconds, re- 
spectively; 256 acquisitions were performed. Water 
suppression was achieved by three consecutive 
CHESS pulses followed by dephasing radients [10]. 
None of the patients had ever received stereotaxic bi- 
opsy, open surgery, or radiation therapy before MRS. 
Between MR imaging and MRS was a delay of at least 
1 day to minimize possible spectral disturbances 
caused by the application of the paramagnetic contrast 
agent. In eight patients contralateral normal-appear- 
ing matter was also investigated. Stereotaxic biopsy or 
open surgery was performed within a few days after 
MRS. One patient returned to MRS 3 months after 
radiation therapy. 
Spectra were postprocessed with a correction for 
residual eddy currents [11], zero-filling to 4096 data 
points, Gaussian filtering (time constant: 256 millisec- 
onds), and, if necessary, phase corrected in zero and 
first order after Fourier transformation. Peak areas 
were calculated using the standard equipment soft- 
ware. The resonances of lipids, proteins, and lactate 
(Lip) between 0.7 and 1.7 ppm; the N-acetylated com- 
pounds (NAA) at 2.0 ppm; macromolecules, gluta- 
mine, and glutamate (MGG) between 2.1 and 2.55 
ppm; total creatine (Cr) at 3.0 ppm; the choline- 
containing compounds (Cho) at 3.2 ppm; and the reso- 
nance of both glycine and myo-inositol (GI) at 3.55 
ppm were integrated. For quantification of the NAA 
peak, the upfield half of the resonance was integrated 
and the result multiplied by a factor of 2. Severe lipid 
contamination effects could be excluded by position- 
ing the volume of interest sufficiently apart from the 
skull and by applying slice selection gradients of 3 
mT/m. This was necessary because the lipid reso- 
nances played an important role in the metabolic las- 
sification (see below). 
The study protocol was approved by the Ethical 
Committee of the Basel University Hospital. All sub- 
jects were informed of the purpose of the study and 
gave their consent. 
Metabolic classification 
For each measured subject he ratio of the area of each 
metabolite over the area of Cr was calculated. Thus, 
five ratios were obtained for each patient. The ratios 
were then projected along metabolic coordinates 
(ODV1, ODV2) into a two-dimensional space. These 
coordinates had been determined using the orthonor- 
mal discriminant vector method (ODV) [12] in a pre- 
vious study of 13 patients with the same inclusion 
criteria (suspected glial brain tumor, no previous 
therapy, biopsy, or surgery before MRS) and 8 healthy 
volunteers, all measured with identical measurement 
parameters on a different MR system, aSiemens Mag- 
netom Helicon GBS II at 2.0 T [6]. In this study, the 
coordinates shown in equation 1 permitted a separa- 
tion of all investigated cases into three distinct groups: 
healthy volunteers, low-grade gliomas (i.e., astrocy- 
toma and oligodendroglioma World Health Organiza- 
tion grade I and II), and high-grade gliomas (astrocy- 
toma grade III and glioblastoma multiforme): 
ODV 1 = 0.4232 NAA/Cr  - 0.3116 MGG/Cr 
- 0.6605 Cho/Cr - 0.5348 GI/Cr 
- 0.0372 Lip/Cr, (1) 
ODV 2 = 0.4422 NAA/Cr  - 0.3909 MGG/Cr 
+ 0.7321 Cho/Cr - 0.3317 GI/Cr 
+ 0.0748 Lip/Cr. 
Each measured subject was thus represented by one 
single point in the two-dimensional metabolite space. 
Figure I displays the distribution of the previous cases 
(solid symbols) within this space. High-grade and 
low-grade tumors, as well as healthy volunteers, could 
clearly be separated by ODV. 
In the present study the same coordinates were used 
for a histological assignment of 37 new spectra. The 
position of each point of the new subject group (with 
unknown histology, when classification was done) 
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Fig. 1. Distribution of all 
investigated cases within 
the metabolic space as 
defined by equation 1. 
The outlined areas form 
the basic features as re- 
gions of different histol- 
ogy found in the base 
study (solid symbols).  
The new cases of the 
present study are indi- 
"cated by open symbols 
and crosses. The cases 
were classified as HG or 
LG or as HV depending 
on distance from previ- 
ously defined regions. 
The data point of one 
glioblastoma multiforme 
is located beyond the left 
edge of the f igure at 
(-11.2, 22.4). A II, astrocy- 
toma grade II; A III, astro- 
cytoma grade III; GBM, 
glioblastoma multiforme; 
cNAM, contralateral nor- 
mal-appearing matter. 
was compared with the metabolic features of the pre- 
vious study (with known histology). The new subjects 
were then assigned to the group to which the distance 
was smallest: healthy (HV), low-grade glioma (LG), or 
high-grade glioma (HG). This histological assignment 
by MRS and ODV was then compared with the his- 
tology obtained afterwards by stereotaxic biopsy. 
RESULTS 
Stereotaxic biopsy revealed 10 glioblastomas multi- 
forme (GBM), two astrocytomas grade III, and five 
astrocytomas grade II. Metabolic oordinates were cal- 
culated from the spectral results, as described above. 
The new cases are shown in Fig. 1 (open symbols and 
crosses), together with the results of the base study. 
All 10 GBM were nearest to the high-grade gliomas of 
the base study. Four of five astrocytomas grade II 
were assigned to the LG gliomas, one to the HG. The 
two astrocytomas grade III were assigned as one LG 
and one HG. All HV were nearest o the HV group of 
the base study, and contralateral normal-appearing 
matter of tumor patients was assigned as normal in six 
cases and as low grade in two cases. 
Figure 2 shows the tumor spectra of two patients 
with glioblastoma multiforme. In metabolic space, the 
spectra shown in Fig. 2 are located at the coordinates 
(-11.2, 22.4) and (-3.69, 3.25), respectively (Fig. 1). 
Both spectra were clearly assigned to the HG gliomas, 
although the spectra look very different. 
The patient returning for a second MRS after stereo- 
taxic biopsy and radiation therapy had a GBM. The 
spectra were located at (-2.55, 2.17) and (-2.83, 2.57) 
(before and after biopsy/therapy, respectively). They 
could be correctly assigned in both measurements to 
the HG group (Fig. 1). 
DISCUSSION 
The spectra from the glioblastoma multiforme show 
the largest spread within the metabolic space, indicat- 
ing their heterogeneous and dedifferentiated tissue. 
Nevertheless, all 11 investigations of GBM were as- 
signed correctly. Four of the five astrocytomas grade II 
were also assigned correctly, and the fifth was located 
between the features of low- and high-grade gliomas. 
This measurement had been performed within the 
cysts of a large cystic astrocytoma. Here, the integral 
of the choline signal was approximately as large as all 
of the remaining resonances together, and lipid signals 
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Fig. 2. MR spectra of two different glioblastomas multi- 
forme. Both spectra were correctly assigned as high- 
grade glioma. 
were also small. Thus, this case was located slightly 
closer to the HG group in metabolic space, inasmuch 
as choline has, according to equation 1, the strongest 
effect on the metabolic coordinates. On the other hand, 
the general state of the patient was not very healthy, 
and morphological histology, as determined by both 
computed tomography and MR imaging, resulted also 
in a high-grade glioma. Especially this case might 
demonstrate he problems encountered with the very 
limited size of stereotaxic material and thus the pos- 
sible usefulness of the technique presented as an ad- 
ditional diagnostic tool for an improved characteriza- 
tion of human glioma. 
The assignment of the two astrocytomas grade III 
was most difficult. One of the astrocytomas grade III 
was located close to the LG group, and the other was 
nearer to the high-grade gliomas. At the moment we 
can only speculate whether this different outcome in 
assignment reflects the difficulties in classifying tumor 
histology by brain biopsy analysis or perhaps a differ- 
ent outcome of the patient's course. 
The points of all nine HV were assigned correctly, 
but some were located close to the area of low-grade 
gliomas. This finding can be explained by the fact that 
the humps of lipids, proteins, and lactate were not 
integrated in the HV spectra of the base study. Be- 
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cause these resonances may also appear in short echo 
time 1H-MRS of healthy subjects [13-15], the indicated 
area of HV in Fig. I might have to be slightly extended 
to the LG area. The use of better localization sequences 
with shorter TE and stronger slice selection gradients 
to prevent lipid contamination could improve the 
separability of the pathology groups; these were, how- 
ever, not available at the time of the base study. 
The use of identical measurement parameters in all 
investigations i  crucial for the success of the pre- 
sented approach. The change from a main magnetic 
field strength of 2.0 T to 1.5 T could not be avoided in 
the present study, but it should have only a minor 
influence on the evaluated peak ratios [16]. More im- 
portant is the optimum choice of the volume of inter- 
est within the center of the tumor. The present study 
also clearly demonstrates that the choice of contra- or 
ipsilateral normal-appearing tissue as an internal ref- 
erence in tumor patients may lead to false spectral 
interpretations. The approach operates very well, al- 
though singular metabolic ratios should in principle 
not be used to quantitate brain metabolites [6,17]. 
Depending on the quantification method, absolutely 
quantified proton spectra of tumor tissue might be 
seriously influenced by altered relaxation times of the 
metabolites of interest. Normally, these relaxation 
time changes will be in the same direction for different 
metabolites. In this case we can partly reduce this ad- 
dition source of quantification error just by the use of 
metabolite peak ratios, as has been done in the ap- 
proach presented. Hence, the linear combination of 
metabolite peak ratios remains probably the fastest 
and most model-independent way to classify brain tu- 
mor spectra noninvasively. 
CONCLUSION 
Single-voxel 1H-MRS at short echo times (TE ~ 50 
milliseconds) allows a differential diagnosis of glial 
brain tumors by the use of linear combinations of 
metabolic ratios plotted in a two-dimensional space. 
The method fails only in a few cases. A careful obser- 
vation of the MR images may be necessary in the cases 
where the assignment is ambiguous. The approach 
does not require a method for an absolute quantifica- 
tion of the metabolites if the same or very similar mea- 
surement parameters are used as in the base study. 
The change from 2.0 to 1.5 T between base and actual 
study had no measurable deteriorating effect on the 
results of the present study. The method is simple and 
noninvasive and can easily be performed as part of 
routine MR imaging within about 15 minutes. Contra- 
lateral normal-appearing brain matter may show 
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pathological spectra and should not be taken as a ref- 9. 
erence in tumor patients. 
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